Eli Lilly & Co.’s full-year earnings forecast came in line with analysts’ estimates as the company works to fix inventory problems with its new blockbuster obesity and diabetes drugs that weighed on ...

Viking Therapeutics stock plunged early Thursday on an earnings report that included mostly incremental updates for its ...